Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials-Reference-Cited by-同舟云学术

Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials

Published:2022-11-09 Issue:1 Volume:25 Page:108-113
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Ferreira João Pedro¹²³^ORCID,Cleland John G.⁴,Girerd Nicolas³,Bozec Erwan³,Rossignol Patrick³,Pellicori Pierpaolo⁴,Cosmi Franco⁵,Mariottoni Beatrice⁵,Solomon Scott D.⁶,Pitt Bertram⁷,Pfeffer Marc A.⁶,Shah Amil M.⁶,Petutschnigg Johannes⁸,Pieske Burkert⁸,Edelmann Frank⁷,Zannad Faiez²

Affiliation:

1. Cardiovascular R&D Centre – UnIC@RISE, Department of Physiology and Cardiothoracic Surgery Faculty of Medicine of the University of Porto Porto Portugal

2. Internal Medicine Departament Centro Hospitalar de Vila Nova de Gaia/Espinho Vila Nova de Gaia Portugal

3. Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique, 1433, U1116, CHRU de Nancy, F‐CRIN INI‐CRCT Nancy France

4. Robertson Centre for Biostatistics and Clinical Trials University of Glasgow Glasgow UK

5. Department of Cardiology Cortona Hospital Arezzo Italy

6. Division of Cardiovascular Medicine Brigham and Women's Hospital Boston MA USA

7. Division of Cardiology University of Michigan Ann Arbor MI USA

8. Department of Internal Medicine and Cardiology, Campus Virchow Klinikum Charité University Medicine Berlin, Berlin, Germany & German Centre for Cardiovascular Research (DZHK) Partner Site Berlin Berlin Germany

Funder

FP7 Ideas: European Research Council

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2726

Reference41 articles.

1. Spironolactone for Heart Failure with Preserved Ejection Fraction

2. Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

3. Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure